Drug Shortage Report for KALETRA

Last updated on 2021-06-22

History

Report ID	138134
Drug Identification Number	02312301
Brand name	KALETRA
Common or Proper name	lopinavir/ritonavir tablets
Company Name	ABBVIE CORPORATION
Market Status	MARKETED
Active Ingredient(s)	LOPINAVIR RITONAVIR
Strength(s)	100MG 25MG
Dosage form(s)	TABLET
Route of administration	ORAL ORAL
Packaging size	60 Tablets bottle
ATC code	J05AR
ATC description	DIRECT ACTING ANTIVIRALS
Reason for shortage	Demand increase for the drug.
Anticipated start date	2021-06-21
Actual start date	2021-06-21
Estimated end date	2021-06-22
Actual end date	2021-06-21
Shortage status	Resolved
Updated date	2021-06-22
Company comments	As a result of an increase in demand for KALETRA® (lopinavir/ritonavir film-coated tablets, 100/25mg), we are closely monitoring our inventory of KALETRA film-coated tablets (100/25mg). KALETRA film-coated tablets (200/50 mg) and KALETRA oral solution (80/20 mg/mL) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270.
Health Canada comments
Tier 3 Status	No
Contact Address	8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1
Company contact information	Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 30